Cytochrome P450 2C9 variants influence response to celecoxib for prevention of colorectal adenoma. [electronic resource]
Producer: 20090708Description: 2127-2136.e1 p. digitalISSN:- 1528-0012
- Adenoma -- drug therapy
- Adult
- Aged
- Aged, 80 and over
- Aryl Hydrocarbon Hydroxylases -- drug effects
- Celecoxib
- Colorectal Neoplasms -- drug therapy
- Confidence Intervals
- Cytochrome P-450 CYP2C9
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Genetic Predisposition to Disease
- Genetic Variation
- Genotype
- Humans
- Male
- Middle Aged
- Pharmacogenetics
- Probability
- Pyrazoles -- therapeutic use
- Reference Values
- Risk Assessment
- Sensitivity and Specificity
- Sulfonamides -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.